OragenicsOGEN

13F holders, Q1 2025 (March 31)
22holders −2
3new positions
5sold out
$0.21avg. 13F price*

At the end of Q1 2025, 22 institutions reported holding Oragenics Inc. (OGEN) in their 13F filings, down 2 from Q4 2024. 3 opened new positions and 5 sold out. The largest holders were Geode Capital Management, LLC ($18K), Grey Ledge Advisors, LLC ($6K) and Two Sigma Securities, LLC ($5K).

Company
Oragenics Inc.
CUSIP
684023500
Latest filing quarter
Q1 2025

History

Number of 13F holders

0510152025 Q1 2024: 14Q1 2024Q2 2024: 16Q2 2024Q3 2024: 16Q3 2024Q4 2024: 24Q4 2024Q1 2025: 22Q1 2025

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions3$3K
Exits5$10K

All 13F filers, Q4 2024 → Q1 2025: 82,680 shares bought and 44,447 shares sold, net +38,233 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 22 holders

Geode Capital Management, LLC 0.00% Add +120.4% 84,826 $18K
Grey Ledge Advisors, LLC 0.00% Add +53.1% 30,927 $6K
Two Sigma Securities, LLC 0.00% Add +48.0% 25,107 $5K
XTX Topco Ltd 0.00% Reduce -36.2% 24,845 $5K
BlackRock, Inc. 0.00% No change 21,059 $4K
Lionsbridge Wealth Management LLC 0.00% No change 20,000 $4K
Two Sigma Investments, LP 0.00% Reduce -7.3% 18,231 $4K
Mutual Advisors, LLC 0.00% New 16,000 $3K
HBK Sorce Advisory LLC 0.00% No change 13,626 $3K
Tower Research Capital LLC (TRC) 0.00% Reduce -1.1% 7,477 $2K
UBS Group AG 0.00% Add +18.5% 5,985 $1K
Morgan Stanley 0.00% Add +5.9% 4,593 $965
Hexagon Capital Partners LLC 0.00% New 275 $58
Bank of America Corp. 0.00% Add +2.5% 208 $44
JPMorgan Chase & Co. 0.00% Reduce -40.4% 186 $39
Activest Wealth Management 0.00% No change 34 $7
SBI Securities Co., Ltd. 0.00% No change 29 $6
Evermay Wealth Management LLC 0.00% No change 2 $1
Royal Bank of Canada 0.00% No change 3 $0
Chesapeake Asset Management LLC 0.00% No change 3 $0
NewEdge Advisors, LLC 0.00% No change 1 $0
Farther Finance Advisors, LLC 0.00% New 1 $0

"% of holder's portfolio" is OGEN's weight in each manager's 13F, not the share of Oragenics Inc. the manager owns.